PPE Cardiac Risk (AHA 14-Element) Calculator

Clinical calculation support · Verify results before clinical use

Cardiovascular screening checklist

Answer each history and examination item. A positive response is a screening signal for clinical review, not a quantified risk score.

—Positive items

Exertional chest pain, discomfort, tightness, or pressure

Symptoms associated with exercise.

Unexplained syncope or near-syncope

Especially during or immediately after exertion; consider the clinical context.

Excessive, unexplained exertional dyspnea, fatigue, or palpitations

Symptoms associated with exercise.

Previous recognition of a heart murmur

A prior clinician-identified murmur.

History of elevated systemic blood pressure

Previously identified elevated blood pressure.

Previously restricted from sports participation

Any previous restriction related to sports participation.

Previous cardiac testing ordered by a physician

For example, ECG, echocardiography, or another cardiac test.

Premature death before age 50 attributable to heart disease in a relative

Sudden and unexpected death or another death attributable to heart disease.

Disability from heart disease in a close relative younger than 50 years

A close relative with disability due to heart disease before age 50.

Family history of cardiomyopathy, channelopathy, Marfan syndrome, or clinically significant arrhythmia

Includes hypertrophic/dilated cardiomyopathy, long-QT syndrome, and other ion-channel disorders.

Heart murmur on examination

Auscultate sitting and standing, or use a Valsalva manoeuvre when appropriate.

Abnormal or diminished femoral pulses

Assess for possible aortic coarctation.

Physical stigmata suggestive of Marfan syndrome

Assess the overall phenotype and clinical context.

Record the measured value as a clinical observation. The AHA checklist calls for seated brachial blood pressure measurement (ideally in both arms); this calculator does not apply a universal SBP cutoff because interpretation depends on age and clinical context.

If the history or examination cannot be established, complete the assessment before relying on the result; do not treat an unanswered item as a confirmed negative.

How to use this checklist

The AHA 14-element screening checklist combines seven personal-history items, three family-history items, and four physical-examination elements to identify findings that may warrant further cardiovascular evaluation in competitive athletes.

Interpretation principles

  • The checklist is a structured history and physical-examination aid, not a weighted score or an estimate of an individual's absolute risk.
  • Any positive item warrants clinical review and follow-up appropriate to the finding. The urgency and investigations depend on symptoms, examination, age, family history, and clinician assessment.
  • A negative checklist does not exclude all cardiovascular disease and should not replace a complete preparticipation evaluation.
  • Blood pressure should be measured with an appropriate cuff and interpreted for the athlete's age and clinical context. This tool records SBP but does not classify it using a single universal threshold.
  • ECG or echocardiography decisions should follow applicable guidance, local pathways, and clinical judgement; they are not automatically required for every positive response.

Checklist structure

  • Personal history (1–7): exertional symptoms, murmur history, elevated blood pressure history, prior sports restriction, and physician-ordered cardiac testing.
  • Family history (8–10): premature heart-disease death, disability from heart disease in a close relative younger than 50, and inherited or clinically significant cardiac conditions.
  • Physical examination (11–14): heart murmur, femoral pulses, Marfan stigmata, and seated brachial blood pressure.

References

Maron BJ, et al. Recommendations and Considerations Related to Preparticipation Screening for Cardiovascular Abnormalities in Competitive Athletes.Circulation. 2007;115:1643–1655. DOI: 10.1161/CIRCULATIONAHA.107.181423.
American Heart Association / American College of Cardiology.Assessment of the 12-Lead Electrocardiogram as a Screening Test for Cardiovascular Disease in Healthy General Populations of Young People (12–25 Years of Age): Scientific Statement. J Am Coll Cardiol. 2014. DOI: 10.1016/j.jacc.2014.05.006.
American Heart Association / American College of Cardiology.Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement. Circulation. 2025. Full text on PubMed Central.
Clinical disclaimer: This tool supports, but does not replace, a complete preparticipation history and physical examination or clinical decision-making. It is not intended to diagnose disease, quantify sudden-cardiac-death risk, or independently clear or disqualify an athlete from sport. Concerning symptoms such as exertional syncope or chest pain require timely clinical assessment.